Should I Buy SPXC? SPXC 2026 Analysis

Should You Buy SPX Technologies Inc (SPXC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

222.320

1 Day change

1.97%

52 Week Range

233.710

Analysis Updated At

2026/01/30

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

BUY now. SPXC is pulling back to a key support zone (~209/205) while the broader trend remains bullish (SMA_5 > SMA_20 > SMA_200). With hedge funds aggressively increasing buying, options open interest skewed strongly to calls (bullish positioning), and the SwingMax swing-trade entry still essentially “fresh” (+1.13% since 2026-01-06), the current dip offers a good immediate-entry swing setup for an impatient buyer. Main near-term overhang is insider selling and weakening short-term momentum (MACD), but the setup favors a rebound from support into the next catalyst window (earnings 2026-02-24 after hours).

Technical Analysis

Trend/price action: Despite today’s -1.62% regular-session drop to 208.41 (post-market), the moving-average structure is still bullish (SMA_5 > SMA_20 > SMA_200), implying the intermediate/long trend remains up. Momentum: MACD histogram is negative (-0.425) and negatively expanding, signaling short-term downside momentum is still active. RSI(6)=35.8 is approaching oversold territory, which often coincides with late-stage pullbacks rather than early-stage selloffs. Levels: Current price (~208.4) is just below S1 (209.084) and not far from S2 (204.993). Pivot resistance is 215.706, then 222.328. Trading plan bias: Favor buying near/around support (209→205 zone) targeting a rebound back toward 216 (pivot) first, then 222 if momentum turns.

Intellectia Proprietary Trading Signals

AI Stock Picker: No signal on given stock today.
SwingMax: Entry signal triggered on 2026-01-06; price is only +1.13% since then, suggesting the swing entry is still actionable at current levels (not extended).

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment/positioning: Open interest put/call ratio at 0.23 is strongly call-skewed (bullish positioning). The option volume put/call ratio at 0.81 is closer to balanced, suggesting no panic hedging today. Volatility: 30D IV (~~34.65) is below historical volatility (~~46.64), implying options are not pricing extreme risk; IV percentile ~62.8 indicates IV is mid-to-higher vs its own range, but not stretched. Liquidity/activity: Today’s options volume is light (38 total; calls 21 vs puts 17), so the signal comes more from positioning (open interest) than from a high-conviction volume surge.

Technical Summary

Sell

Buy

Positive Catalysts

Hedge fund flow: Hedge funds are buying (buying amount +476.98% QoQ), supportive of near-term demand for shares.
Earnings ahead: Next earnings (QDEC
on 2026-02-24 after hours—often a catalyst window for pre-earnings positioning.
Analyst commentary backdrop: Multiple firms highlight durable end-markets (advanced cooling/power-related demand themes; defense technology exposure) and continued growth/flywheel value creation.
Strong recent operating growth (latest reported quarter): 2025/Q3 revenue +22.56% YoY; net income +24.90%; EPS +20.75%.

Neutral/Negative Catalysts

Insider activity: Insiders are selling (selling amount +664.99% MoM), a meaningful near-term sentiment headwind.
Short-term technical momentum: MACD is negative and deteriorating, increasing the odds of a further test of ~205 support before a sustained bounce.
Margins: 2025/Q3 gross margin fell to 36.25% (-3.13% YoY), indicating some profitability pressure despite strong top-line growth.
News relevance: Provided news items are largely biotech-focused (Halozyme/Catalyst) and do not present an obvious SPXC-specific bullish catalyst in this dataset.

Financial Performance

Latest quarter (2025/Q3): Revenue was $592.8M (+22.56% YoY), net income $62.7M (+24.90% YoY), EPS $1.28 (+20.75% YoY). Growth is strong across revenue/earnings, but gross margin declined to 36.25% (-3.13% YoY), suggesting cost/price mix pressures. Overall: solid growth trend with a margin watch item.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Price targets have generally moved higher with several bullish stances, but valuation concerns are present.

2025-12-18 Truist: PT to $216 (from $215), Hold.
2025-12-10 B. Riley: PT to $244 (from $225), Buy.
2025-11-10 Oppenheimer: PT to $240 (from $220), Outperform.
2025-11-10 TD Cowen: Initiated Hold, PT $225, citing elevated valuation. Wall Street pros: durable end-market tailwinds (cooling, power-related demand themes, defense tech), confidence in 2026 setup, and M&A bolstering HVAC portfolio. Wall Street cons: elevated valuation and investor focus on whether demand/backlog growth is peaking.

9 Analyst Rating

Wall Street analysts forecast SPXC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SPXC is 226.88 USD with a low forecast of 210 USD and a high forecast of 244 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

3 Hold

0 Sell

Moderate Buy

Current: 218.020

Low

210

Averages

226.88

High

244

Current: 218.020

Low

210

Averages

226.88

High

244

Truist

Hold

maintain

$215 -> $216

AI Analysis

2025-12-18

Reason

Truist

Price Target

$215 -> $216

AI Analysis

2025-12-18

maintain

Hold

Reason

Truist raised the firm's price target on SPX Technologies to $216 from $215 and keeps a Hold rating on the shares as part of a broader research note previewing Machinery,. Infrastructure Services, and Multi-Industry industrial names in 2026. The firm continues to favor the broader power markets including Transmission & Distribution and Power Generation supported by data centers / AI, though it also believes that investors will be looking for cracks that demand has peaked, and as such backlog growth will be a major focus, particularly as capacity comes online and given the risks associated with hyperscalers, the analyst tells investors in a research note. Construction will be a bright spot with channel destock over and green shoots emerging, supported by Deere's guide for Construction & Forestry up 10% in 2026, and while North America truck orders continue to underwhelm, orders are at a cyclical trough and will improve throughout 2026 as EPA 2027 moves ahead, creating some level of pre-buy, the firm added.

B. Riley

Jeff Van Sinderen

Buy

maintain

$225 -> $244

2025-12-10

Reason

B. Riley

Jeff Van Sinderen

Price Target

$225 -> $244

2025-12-10

maintain

Buy

Reason

B. Riley analyst Jeff Van Sinderen raised the firm's price target on SPX Technologies (SPXC) to $244 from $225 and keeps a Buy rating on the shares. SPX plans to acquire Crawford United's (CRAWA) commercial air handling and coil businesses, broadening its HVAC portfolio with minimal customer overlap and adding well-regarded brands under the Ingenia umbrella, the analyst tells investors in a research note. The deal is expected to support modest growth in 2026 as SPX continues pursuing acquisitions alongside steady organic expansion, B. Riley says.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for SPXC

Unlock Now

SPXC Should I Buy

SPXC Should I Buy

Should You Buy SPX Technologies Inc (SPXC) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch